Assessing vaccine safety during a pandemic: Recent experience and lessons learned for the future.

Journal Information

Full Title: Vaccine

Abbreviation: Vaccine

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. KME receives grant funding from the NIH to mentor young investigators and from the CDC to monitor vaccine safety. She is a consultant to Bionet and IBM and a member of Data Safety and Monitoring Boards for Sanofi, X-4 Pharma, Seqirus, Moderna, Pfizer, Merck, Roche, Novavax, and CEPI. MS is head of a department that conducts vaccine safety studies for the European Medicines Agency, AstraZeneca, Pfizer and Janssen. SBB is a consultant to GSK for program planning, receives funding from CEPI and grant funding from the US CDC."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025